Transition from IV to subcutaneous prostacyclin: premature withdrawal?
Shapiro
Shelley
S
Hill
Nicholas S
NS
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D012107:Research Design; D018570:Risk Assessment
D000959:Antihypertensive Agents; D011464:Epoprostenol; C427248:treprostinil